These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prognostic importance of baseline and serial changes in microalbuminuria in patients with resistant hypertension. Salles GF, Cardoso CR, Fiszman R, Muxfeldt ES. Atherosclerosis; 2011 May; 216(1):199-204. PubMed ID: 21315356 [Abstract] [Full Text] [Related]
4. Prevalence of albuminuria and associated cardiovascular risk factors: a community cohort in Namwon City, Korea. Kweon SS, Shin MH, Choi JS, Nam HS, Lee YH, Park KS, Lee JY, Jeong SK. Diabetes Res Clin Pract; 2012 Sep; 97(3):492-8. PubMed ID: 22682946 [Abstract] [Full Text] [Related]
5. Prognostic value of microalbuminuria during antihypertensive treatment in essential hypertension. Pascual JM, Rodilla E, Costa JA, Garcia-Escrich M, Gonzalez C, Redon J. Hypertension; 2014 Dec; 64(6):1228-34. PubMed ID: 25245391 [Abstract] [Full Text] [Related]
7. Urinary albumin excretion is associated with nocturnal systolic blood pressure in resistant hypertensives. Oliveras A, Armario P, Martell-Clarós N, Ruilope LM, de la Sierra A, Spanish Society of Hypertension-Resistant Hypertension Registry. Hypertension; 2011 Mar; 57(3):556-60. PubMed ID: 21220713 [Abstract] [Full Text] [Related]
8. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring. Ríos MT, Domínguez-Sardiña M, Ayala DE, Gomara S, Sineiro E, Pousa L, Callejas PA, Fontao MJ, Fernández JR, Hermida RC, Hygia Project Investigators. Chronobiol Int; 2013 Mar; 30(1-2):207-20. PubMed ID: 23077975 [Abstract] [Full Text] [Related]
10. Risk factors for development of microalbuminuria in diabetic and nondiabetic normoalbuminuric hypertensives with high or very high cardiovascular risk - a twelve-month follow-up study. Cotter J, Oliveira P, Cunha P, Polónia J. Nephron Clin Pract; 2009 Mar; 113(1):c8-15. PubMed ID: 19590230 [Abstract] [Full Text] [Related]
11. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Arnlöv J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D, Benjamin EJ, D'Agostino RB, Vasan RS. Circulation; 2005 Aug 16; 112(7):969-75. PubMed ID: 16087792 [Abstract] [Full Text] [Related]
12. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox. Hermida RC, Ayala DE, Mojón A, Fernández JR. Chronobiol Int; 2013 Mar 16; 30(1-2):87-98. PubMed ID: 23039824 [Abstract] [Full Text] [Related]
14. The combined contribution of albuminuria and glomerular filtration rate to the prediction of cardiovascular mortality in elderly men. Nerpin E, Ingelsson E, Risérus U, Sundström J, Larsson A, Jobs E, Jobs M, Hallan S, Zethelius B, Berglund L, Basu S, Arnlöv J. Nephrol Dial Transplant; 2011 Sep 16; 26(9):2820-7. PubMed ID: 21335440 [Abstract] [Full Text] [Related]
18. The association between metabolic syndrome, microalbuminuria and impaired renal function in the general population: impact on cardiovascular disease and mortality. Klausen KP, Parving HH, Scharling H, Jensen JS. J Intern Med; 2007 Oct 16; 262(4):470-8. PubMed ID: 17875184 [Abstract] [Full Text] [Related]